Lilly bags a license worth US$1.5 billion for a batch of metabolic candidates with Regor Therapeutics
USA – Eli Lilly has formed a multi-year collaboration with China-based Regor Therapeutics...
Read More
Tag: autoimmune disease
Glaxo’s biological agent offers a glimmer of hope for lupus patients
CHINA – GlaxoSmithKline plc has unveiled the world’s first biological agent, Benlysta for...
Read More
LATEST DIGITAL MAGAZINE
